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Abstract
Objective: The present study aims to examine the expression of leukocyte adhesion molecules and renal metabolic
factors in diabetic mouse kidneys with periodontal pathogen Pg-LPS-induced nephropathy.
Background: We recently reported that the glomerular endothelium expresses toll-like receptor (TLR)2 and TLR4 in
diabetic environments and TLR2/4 ligand Porphyromonas (P.) gingivalis lipopolysaccharides (Pg-LPS) induce
nephropathy in diabetic mice. It is thought that Pg-LPS promotes the chronic inflammation with the overexpression
of leukocyte adhesion molecules and renal-specific metabolic enzymes by the recognition of Pg-LPS via TLR in the
diabetic kidneys. There have been no reports of the effects of periodontopathic bacteria on the expression of
leukocyte adhesion molecules and the accumulation of physiologically active substances in the kidney.
Methods: The immunohistochemical investigation was performed on diabetic mouse kidney with Pg-LPS-induced
nephropathy with glomerulosclerosis in glomeruli.
Results: There were no vessels which expressed vascular cell adhesion molecule-1 (VCAM-1), E-selectin, or fibroblast
growth factor (FGF) 23 in streptozotocin (STZ)-induced diabetic ICR mice (STZ-ICR), or in healthy ICR mice
administered Pg-LPS (LPS-ICR). However, in diabetic ICR mouse kidneys with Pg-LPS-induced nephropathy (LPS-STZ)
the expression of VCAM-1 and the accumulation of FGF23 were observed in renal tubules and glomeruli, and the
expression of E-selectin was observed in renal parenchyma and glomeruli. The angiotensin-converting enzyme 2
(ACE2) was detected in the proximal tubules but not in other regions of ICR, STZ-ICR, or LPS-ICR. In LPS-STZ ACE2
was detected both in renal tubules as well as in glomeruli. The Mac-1 and podoplanin-positive cells increased in
the renal parenchyma with diabetic condition and there was the distribution of a large number of Mac-1-positive
cells in LPS-STZ.
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Conclusions: The Pg-LPS may induce diabetic renal inflammation such as glomerulosclerosis and tubulitis with
infiltration of Mac-1/podoplanin positive macrophages via glomerular overexpression of VCAM-1 and E-selectin,
resulting in accumulation of both ACE2 and FGF23 which were unmetabolized with the inflammation-induced
kidney damage under the diabetic condition. Periodontitis may be a critical factor in the progress of nephropathy
in diabetic patients.
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Background
Diabetic nephropathy is a serious complication in dia-
betes mellitus, caused by glomerulosclerosis, with renal
failure arising from dysfunction of glomerular capillaries.
Critical factors in diabetic nephropathy have been
thought to be advanced glycation end products (AGE)
and hydroxyl radicals which induce oxidative stress and
the production of various cytokines through the recogni-
tion of AGE in a hyperglycemic environment [1–3].
However, the factors which cause individual differences
in the development of nephropathy in diabetic patients
are not well elucidated. Hyperglycemia induces the ex-
pression of TLR2 and TLR4 through PKC-α and PKC-δ,
respectively, with the stimulation of NADPH oxidase in
monocytes [4, 5]. The renal metabolic recognition of
AGE by not only AGE receptor but also toll-like recep-
tor (TLR) has been suggested as one candidate for the
occurrence of diabetic nephropathy [6–8]. The TLR is a
sensor for bacterial components like lipopolysaccharide
(LPS) and high levels of expression of TLR2 and TLR4
has been reported in blood cells of diabetic nephropathy
patients [9–13]. It has been established that the TLR lig-
and engagement induces the production of inflammatory
cytokines as well as leukocyte adhesion molecules, which
activate renal inflammation causing glomerulosclerosis
[14–18]. There are also reports that the periodontal
pathogen Porphyromonas (P.) gingivalis becomes a risk
factor in cerebrovascular diseases and atherosclerosis
[19, 20]. Lipopolysaccharides (LPS) are produced in the
outer membrane of P. gingivalis and act as not only a
periodontal pathogen leading to periodontal tissue de-
struction but also a risk factor in cardiovascular disor-
ders [21, 22]. It is well studied that P. gingivalis LPS (Pg-
LPS) is recognized by host defense systems via TLR4 to
Pg-LPS lipid A and via TLR2 through co-purifying mole-
cules in the Pg-LPS prep in LPS-accumulated organs
and induces the expression of leukocyte adhesion mole-
cules [8, 23–25].
The expression of TLR2/TLR4, and adhesion mole-
cules go up in kidneys of diabetic mice [8, 11, 26]. We
recently reported that the glomerular endothelium of
streptozotocin (STZ)-induced diabetic mice expresses
TLR2 and TLR4 genes and proteins in glomeruli [27],
and that all Pg-LPS-administered diabetic mice reached
the humane endpoint during the period in which all of
the diabetic mice without the LPS administration and
Pg-LPS-administered non-diabetic mice lived without
any symptoms [28]. In diabetic mice Pg-LPS promoted
the production of urinary protein and glomerulosclerosis
with the accumulation of type 1 collagen and inflamma-
tory cytokines in glomeruli. Further, the progress of dia-
betic nephropathy was suppressed in TLR4 blockage
Eritoran-administered diabetic mice [29]. Since the se-
vere periodontitis causes bacteremia, it is thought that
microorganisms of the oral cavity enter the renal circula-
tion of patients with severe periodontal disease through
the systemic circulation. It appears that Pg-LPS accumu-
lated in glomeruli may induce chronic renal inflamma-
tion as a result of the leukocyte migration.
The abnormal and overexpression of leukocyte ad-
hesion molecules, renal metabolic enzymes, and
physiologically active substance has been reported in
the kidneys of diabetic and other renal autoimmune
diseases, such as erythematosus and IgA nephropathy.
However, there have been no reports of the effects of
periodontopathic bacteria on the expression of
leukocyte adhesion molecules and the accumulation
of physiologically active substances in the kidney. The
overexpression of vascular cell adhesion molecule-1
(VCAM-1) is observed in the renal proximal tubules
in renal immune diseases with tubulitis by acute renal
allograft rejection [30–34]. The overexpression of E-
selectin is observed on intertubular capillaries in
glomerulonephritis [35, 36]. Osteocyte-derived hor-
mone fibroblast growth factor (FGF) 23 acts as a key
regulator of the renal phosphate metabolism which
reduces renal phosphate uptake. In chronic kidney
disease serum FGF23 levels are massively elevated
[37–39]. Angiotensin-converting enzyme 2 (ACE2), a
monocarboxypeptidase, that cleaves a typical renal
pressor hormone angiotensin (Ang) II into Ang 1–7
and degrades Ang I to Ang 1–9, displays antihyper-
tensive and organ-protective effects. The ACE2 is
usually observed in proximal tubular epithelial cells
but increases in diabetic kidney and hypertensive
renal diseases [40, 41]. Considering these findings, the
overexpression of leukocyte adhesion molecules
and accumulation of unmetabolized renal-specific
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hormone, and enzymes may occur in diabetic kidneys
by the renal inflammation associated with TLR recog-
nition of P. gingivalis. The present study aims to
examine the expression of leukocyte adhesion mole-
cules and FGF23, and ACE2 in the mouse kidney
with Pg-LPS-induced diabetic nephropathy.
Methods
Animals
The animal study was conducted to investigate the
expression of VCAM-1, E-selection, FGF23, and
ACE2 in Pg-LPS-induced diabetic nephropathy. The
animal use protocol of the experiments was approved
by the Animal Experiment Committee of Fukuoka
Dental College (No. 19010). The study in the present
report used 4 groups (non-treated control, LPS-
administered non-diabetic control, diabetic control,
LPS-administered diabetic experimental) with 6 mice
in each group. We decided the animal number ac-
cording to the decision by the Animal Experiment
Committee of Fukuoka Dental College based on the
appropriate number of animals in biomedical research
from the viewpoint of animal welfare [42]. The num-
ber of animals that can set the probability of α error
to an appropriate low level is 5 in general animal
studies. So, in the case of genetically identical animal
groups of the same lineage, 5 or more animals per
group, and the test using 4 groups including the con-
trol group, are considered appropriate. All experimen-
tal specimens were harvested from euthanized mice
and the experimental protocol followed ARRIVE
guidelines. The 4-week-old male mice of the ICR
closed line were purchased from a commercial vendor
(Kyudo, Fukuoka, Japan). Animal upkeep and experi-
ments were performed in the Fukuoka Dental College
Animal Center under the following conditions and
procedures described elsewhere [29]: normal feeding
in a 100% controlled atmosphere which had passed
an examination for bacteria in a room where the
temperature and humidity were completely controlled.
The health status and humane endpoints of the mice
were assessed daily and mice which had lost the abil-
ity to ambulate and to access food or water were
euthanized.
Anesthesia and euthanasia were conducted in com-
pliance with the AVMA guidelines for the euthanasia
of animals 2020 Edition and with the methods in the
explanation of standards for rearing and storage of
experimental animals and relief of pain, which was
established by the Study Group on Standards for
Animal Breeding and Storage in the Japanese Minis-
try of the Environment. Namely, euthanasia was per-
formed by induction anesthesia (1 l/min of 2%
isoflurane mixed with 30% oxygen and 70% nitrous
oxide with an anaesthetic apparatus) followed by in-
traperitoneal injection with sodium pentobarbital
(150 mg/kg, Sumitomo Dainippon Pharma Co., Ltd.,
Japan) and cervical dislocation. For drug administra-
tion inhalation anesthesia with 5% concentration iso-
flurane was performed to mice placed in an
anesthesia box with careful observation. For blood
sampling inhalation anesthesia or abdominal
anesthesia was performed. Namely, in inhalation
anesthesia isoflurane was initially introduced at a
concentration of 4–5% and then maintained at about
2–3%. The abdominal anesthesia was performed by
intraperitoneal administration of anesthetic and seda-
tive mixture: medetomidine chloride (0.3 mg/kg,
Meiji Seika Pharma Co., Ltd., Tokyo, Japan), midazo-
lam (4 mg/kg, Maruishi Pharmaceutical Co., Ltd.,
Osaka, Japan), and butorphanol tartrate (5 mg/kg,
Meiji Seika).
The STZ-injected ICR mice were used as a diabetic
model and STZ and Pg-LPS injected ICR mice were
used as a Pg-LPS-induced diabetic nephropathy
model. Mice were given a single intraperitoneal in-
jection of STZ (Sigma-Aldrich Japan, Tokyo, Japan)
and the blood glucose of mice were checked by a
Glutest Sensor (Sanwa Kagaku Kenkyusyo CO.,
LTD., Nagoya, Japan) twice a week after the injec-
tion. The STZ-injected ICR mice which showed ex-
tremely elevated blood glucose levels of over 600
mg/dl were used as STZ-induced diabetic mice
(STZ-ICR). The Pg-LPS of 3 mg/kg (LD50 = 30 mg/kg
body weight; Invivogen, San Diego, California, USA)
which had been confirmed to have no effect on the
health condition in healthy ICR in our previous
study was consecutively injected just below the buc-
cal mucosa of ICR once a week for 4 months. Mice
were monitored for sugar, protein, and bleeding in
urine by urine reagent strips (Uriace, Terumo Cor-
poration, Tokyo, Japan), and the blood which col-
lected from the tail vein under anesthesia was
analyzed for blood urea nitrogen (BUN) and creatin-
ine (CRE) by Kyudo Co., LTD (Tosu, Japan). When
mice showed strongly positive for sugar and protein
in urine by the reagent strips, and simultaneously
showed the BUN levels of above 40 mg/dl and the
CRE levels of above 0.7 mg/dl, they were used as
STZ and Pg-LPS-induced diabetic nephropathy mice
(LPS-STZ) according to our previous study [29]. In
summary, the present study was performed with 24
ICR mice divided into four groups (n = 6 per group)
which is the smallest unit to achieve reliable statis-
tical processing: groups of mice without any treat-
ment (healthy control, ICR), ICR with only LPS
treatment (experimental infection model, LPS-ICR),
ICR with only STZ treatment (experimental diabetes
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model, STZ-ICR), and ICR with LPS and STZ treat-
ment (experimental diabetic nephropathy model,
LPS-STZ). All mice in the experimental groups were
maintained by careful observation every day and
were euthanized at the end of the designated period
of the experiments, and tissue from the mice was
collected.
Immunohistochemistry
The present study performed the investigation by im-
munohistochemistry following the method described
elsewhere [29]. Briefly, frozen mouse kidney tissue
sections were fixed in 100% methanol and treated
with primary antibodies (1 μg/ml): hamster monoclo-
nal anti-mouse podoplanin clone 8.8.1 (#127402, Bio-
Legend Inc., San Diego, CA, USA) as a well-known
podocyte and macrophage marker, rat monoclonal
anti-mouse E-selectin/CD62E (#112734, R&D Systems
Inc., Minneapolis, MN, USA), rat monoclonal anti-
mouse VCAM-1/CD106 (#96419, R&D Systems),
rabbit polyclonal anti-mouse FGF23 (#bs-5768R, Bioss
Inc., Boston, MA, USA), rabbit polyclonal ACE2
(#ab15348, Abcam plc., Cambridge, UK), and rat poly-
clonal anti-mouse CD11b/macrophage-1/Mac-1 clone
M1/70 (#557394, BD Biosciences, San Jose, CA, USA).
After the treatment the sections were exposed with
secondary antibodies (0.5 μg/ml): Alexa Fluor 488 or
568-conjugated goat anti-hamster (#A21110, Thermo
Fisher Scientific Inc., Molecular Probes Invitrogen,
Eugene, OR), goat anti-rabbit (#A11077, Thermo), or
goat anti-rat IgGs (A11011, Thermo). The immuno-
stained sections were examined by microscope digital
camera systems with a CFI Plan Apo Lambda lens
series and DS-Ri2/Qi2 (Nikon Corp., Tokyo, Japan).
Fig. 1 Immunostaining of VCAM-1 in the diabetic mouse kidney with Pg-LPS-induced nephropathy. Hematoxylin-Eosin staining (HE) (left column);
immunostaining for VCAM-1 (red) (center column); and merged immunostaining for VCAM-1 and podoplanin (green) (right column), with DAPI
staining of nuclei (blue). The glomerular epithelial cells were immunostained by anti-podoplanin to be able to discriminate glomeruli (arrows).
Reaction with anti-VCAM-1 were not identified in LPS-ICR (top row) or in STZ-ICR (middle row) while the reaction was identified in renal tubules
(arrowheads) and in glomeruli (yellow arrowheads) LPS-STZ (bottom row). Podoplanin-positive macrophages were also identified in STZ-ICR
(yellow arrows). Bars: 100 μm
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All experiments were replicated several times [5–10]
with different sections.
Measurements of immunostained area
Immunostained areas were captured under the same
conditions and measured in 20 area of 4 sections for
each immunostaining in microscopic images at 200x
magnification by ImageJ (National Institutes of
Health, Bethesda, MD) as described elsewhere [27–
29]. The values were obtained by sum of the surface
areas of pixel regions recognized by ImageJ in the
sections unresponsive to the secondary antibody
alone. The relative expression area reacted with pri-
mary antibodies was expressed by arbitrary units of
the ratio: positive area of antibody reactions in the
sections of STZ-ICR and LPS-STZ / the area of
LPS-ICR.
Statistics
All experiments were repeated five times, and data are
expressed as the mean + SD. The statistical significance
of differences (P < 0.01) was determined by one-way
ANOVA and the two-tailed unpaired Student’s t test
with STATVIEW 4.51 software (Abacus concepts, Cala-
basas, CA, USA). Mean values were calculated with
standard deviation (STDEV). The corresponding author
is fully aware of the group allocation at the different
stages of the experiments. The data analysis and assess-
ments were performed by all co-authors.
Results
Immunostaining of adhesion molecules and leukocytes
Immunoreaction products with anti-VCAM-1 were not
detected in kidneys of ICR (Supplementary 1), LPS-ICR
or STZ-ICR while the products were identified in renal
Fig. 2 Immunostaining of E-selectin in the diabetic mouse kidney with Pg-LPS-induced nephropathy. Hematoxylin-Eosin staining (HE) (left
column); immunostaining for E-selectin (red) (center column); and merged immunostaining for E-selectin and podoplanin (green) (right column),
with DAPI staining of nuclei (blue). The glomerular epithelial cells were immunostained by anti-podoplanin to discriminate glomeruli (arrows).
Reaction with anti-E-selectin were not identified in LPS-ICR (top row) or STZ-ICR (middle row) while the reaction was identified in the whole renal
parenchyma (arrowheads) including glomeruli (yellow arrowheads) in LPS-STZ (bottom row). Podoplanin-positive macrophages were also
identified in diabetic mouse kidneys (yellow arrow). Bars: 100 μm
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tubules and glomeruli of LPS-STZ (Fig. 1). Immunoreac-
tion products with anti-E-selectin were not detected in
kidneys of ICR (Supplementary 1), LPS-ICR or STZ-ICR
while the products were identified in the whole renal
parenchyma including glomeruli of LPS-STZ (Fig. 2).
The Mac-1-positive cells were rarely identified in the
whole renal parenchyma of ICR (Supplementary 1). The
Mac-1-positive cells were identified in the whole renal
parenchyma of LPS-ICR and STZ-ICR (Fig. 3).
Immunostaining of FGF23 and ACE2
Immunoreaction products with anti-FGF23 were not ob-
served in kidneys of ICR (Supplementary 2), LPS-ICR or
in STZ-ICR while the products were identified in the
whole of the renal parenchyma including in glomeruli of
LPS-STZ (Fig. 4). Immunoreaction products with anti-
ACE2 were observed in proximal tubular cells with
brush borders but not in any region including distal
tubular cells in kidneys of ICR (Supplementary 2), LPS-
ICR or STZ-ICR while the products were identified in
proximal and distal tubules, and in glomeruli of LPS-
STZ (Fig. 5).
Quantitative analysis for immunostaining
The renal VCAM-1 and E-selectin positive area were
significantly larger in LPS-STZ than in ICR, LPS-ICR, or
STZ-ICR. The Mac-1 and podoplanin positive area were
significantly larger in LPS-STZ than in ICR, LPS-ICR, or
STZ-ICR, and the Mac-1 and podoplanin positive area
were also significantly larger in STZ-ICR than in ICR, or
LPS-ICR. The renal FGF23 and ACE2 positive area were
significantly larger in LPS-STZ than in ICR, LPS-ICR or
in STZ-ICR.
Fig. 3 Immunostaining of Mac-1 in the diabetic mouse kidney with Pg-LPS-induced nephropathy. Hematoxylin-Eosin staining (HE) (left column),
immunostaining for Mac-1 (red) (center column), and merged immunostaining for Mac-1 and podoplanin (green) (right column), with DAPI
staining of nuclei (blue). The glomerular epithelial cells are immunostained by anti-podoplanin to be able to discriminate glomeruli (arrows). Mac-
1-positive cells (arrowheads) were identified in the whole renal parenchyma (arrowheads) of LPS-ICR (top row) and STZ-ICR (middle row) at a
similar level while the number of Mac-1-positive cells increased in LPS-STZ (bottom row). Podoplanin-positive macrophages were also identified
in diabetic mouse kidneys (yellow arrows). Bars: 100 μm
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Discussion
Expression of leukocyte adhesion molecules in diabetic
mouse kidney with P. gingivalis LPS-induced nephropathy
The expression of adhesion molecules increases in dia-
betic kidneys [30, 33]. An immunoglobulin superfamily
member VCAM-1 binds to the integrins very late
antigen-4/α4β7 on lymphocytes and monocytes, and
provides leukocyte migration from the blood stream into
tissue. The VCAM-1 expression is up-regulated in renal
proximal tubules in several renal chronic diseases, and
the renal proximal tubule is targeted in the renal infiltra-
tion of T cells and monocytes which are rarely found in
normal kidneys [30–34]. A member of selectin family E-
selectin which expresses at the early inflammatory stage
binds to sialylated glycoproteins on leukocytes and pro-
motes the leukocyte weak adhesion, rolling on vessel
walls. The E-selectin is present on intertubular capillar-
ies in glomerulonephritis but never in renal tubules [31,
35, 36]. In this study there were no vessels expressing
VCAM-1 (Fig. 1) or E-selectin (Fig. 2) in kidneys of ICR,
STZ-ICR and LPS-ICR while in LPS-STZ the expression
of VCAM-1 was identified in the renal tubules and
glomeruli (Fig. 1), and the expression of E-selectin was
identified in the renal parenchyma including glomeruli
(Fig. 2). These results suggest that Pg-LPS causes the
renal inflammatory based on the overexpression of
leukocyte adhesion molecule VCAM-1 and E-selectin in
intertubular and glomerular capillaries of LPS-STZ. The
overexpression of VCAM-1 in tubules of renal diseases
has been reported [30–34]. The E-selectin is not
expressed in tubules but it has been shown that renal
intertubular capillaries express E-selectin in renal dis-
eases, and that soluble E-selectin plays a role to promote
glomerulonephritis [31, 35, 36]. The renal immunoreac-
tion with anti-E-selectin in LPS-STZ may be ascribed to
a soluble E-selectin diffused in renal parenchyma around
Fig. 4 Immunostaining of FGF23 in the diabetic mouse kidney with Pg-LPS-induced nephropathy. Hematoxylin-Eosin staining (HE) (left column);
immunostaining for FGF23 (red) (center column); and merged immunostaining for FGF23 and podoplanin (green) (right column), with DAPI
staining of nuclei (blue). The glomerular epithelial cells were immunostained by anti-podoplanin to be able to discriminate glomeruli (arrows).
Reaction with anti-FGF23 was not identified in LPS-ICR (top row) or in STZ-ICR (middle row) while the reaction was identified in the whole renal
parenchyma (arrowheads) and glomeruli (yellow arrowhead) in LPS-STZ (bottom row). Bars: 100 μm
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glomeruli or to the expression of intertubular capillaries.
It is thought that periodontitis induces the tubulitis be-
cause of the overexpression of VCAM-1 and E-selectin
under diabetic conditions and promotes the
nephropathy.
Macrophages, Th17, and lymphatic endothelial cells
express podoplanin [43, 44]. Macrophages are distin-
guishable because size of Th17 is about the same as
the diameter of the nucleus and the renal lymph ves-
sels are much larger as described elsewhere [45]. The
Mac-1 is a heterodimer integrin composed of the αM
(CD11b) and β2(CD18) subunits and is abundantly
expressed on monocyte/macrophages, and is critical
for the adhesion and migration into the extracellular
matrix [46, 47]. In this study Mac-1 positive cells
were detected in kidneys of ICR, STZ-ICR and LPS-
ICR at the similar levels while the distribution of
Mac-1 and podoplanin-positive cells was remarkable
in STZ-ICR compared to LPS-ICR, suggesting that
diabetic conditions promote renal inflammatory
events. The distribution of Mac-1-positive cells was
remarkable in LPS-STZ compared to LPS-ICR or in
STZ-ICR (Fig. 3). Since the overexpression of VCAM-
1 and E-selectin was observed in glomeruli, tubules,
and intertubular capillaries in LPS-STZ, it is thought
that periodontitis provokes chronic inflammatory
events by the renal monocyte-macrophage lineage in-
filtration under diabetic conditions.
Expression of renal physiologically active substances in
diabetic mouse kidneys with P. gingivalis LPS-induced
nephropathy
The FGF23 directly targets proximal tubules to increase
phosphate excretion by downregulating the cell surface
Fig. 5 Immunostaining of ACE2 in the diabetic mouse kidney with Pg-LPS-induced nephropathy. Hematoxylin-Eosin staining (HE) (left column);
immunostaining for ACE2 (red) (center column); and merged immunostaining for ACE2 and podoplanin (green) (right column), with DAPI
staining of nuclei (blue). The glomerular epithelial cells are immunostained by anti-podoplanin to be able to discriminate glomeruli (arrows).
Reaction with anti-ACE2 (arrowheads) was only observed in the proximal tubular cells with brush borders but not in any other region including
distal tubules in LPS-ICR (top row) or in STZ-ICR (middle row) while the reaction was identified in proximal and distal tubules, and in glomeruli
(yellow arrowheads) in LPS-STZ (bottom row). Podoplanin-positive macrophages were also identified in LPS-STZ (yellow arrow). Bars: 100 μm
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expression of the sodium-dependent phosphate trans-
porters in the proximal tubule. The FGF23 lowers serum
phosphorus concentrations by the suppression of phos-
phorus reabsorption in proximal tubules and by active
vitamin D reduction through 1α-hydroxylase suppres-
sion [37–39]. In this study FGF23 was not detected in
kidneys of ICR, STZ-ICR and LPS-ICR while FGF23 was
detectable in renal tubules and glomeruli of LPS-STZ
(Fig. 4), suggesting that Pg-LPS promoted the accumula-
tion of FGF23 in diabetic renal tubules. Generally, dia-
betic nephropathy reduces the ability to excrete
phosphorus in renal tubules. Diabetic nephropathy leads
to a compensatory increase in blood FGF23 levels and
the renal accumulation of unmetabolized FGF23, result-
ing in hypertension and cardiovascular diseases [8, 48–
51]. It may be postulated that periodontitis provokes
renal tubulitis and accumulates unmetabolized FGF23 in
the kidney under diabetic conditions, and that the in-
crease of blood FGF23 in diabetic patients with peri-
odontitis may contribute to provide a prediction of the
nephropathy progression.
It has also been shown that proximal tubular epi-
thelial cells in the brush border express ACE2 and
the expression increase in diabetic kidneys and in
hypertensive renal diseases [40, 41]. In this study
ACE2 were only detected in the proximal tubular
cells but not in any other region in kidneys of ICR,
STZ-ICR and LPS-ICR while ACE2 was detected in
proximal and distal tubules, and in glomeruli in the
kidney of LPS-STZ (Fig. 5). It is thought that peri-
odontitis may induce the overexpression of ACE2 in
proximal and distal tubules to protect renovascular
hypertension in inflamed glomeruli under diabetic
conditions. Periodontitis in patients with diabetic
nephropathy may require attention to increased
renal ACE2 that is a critical SARS-CoV-2 entry fac-
tor [52].
In summary, the renal expression of leukocyte adhe-
sion molecule VCAM-1 and E-selectin, the renal distri-
bution of Mac-1/podoplanin-positive leukocytes, and the
renal accumulation of unmetabolized physiologically ac-
tive molecule FGF-23 and ACE2 were significantly larger
in LPS-STZ than in ICR, LPS-ICR or STZ-ICR (Fig. 6).
Normal inhabitants and LPS derived from intestinal bac-
teria like Escherichia coli enter the liver via the entero-
hepatic (portal) circulation and bacteria/harmful
substances are sterilized there, so sepsis does not occur.
However, oral bacteria enter the systemic circulation dir-
ectly without passing through a detoxification organ
such as the liver. It is the anatomical reason for the head
and neck infections spread through the whole body and
it can be easily predicted that oral bacteria enter the kid-
ney via the systemic circulation [19–22]. The number of
Mac-1 and podoplanin-positive cells was also signifi-
cantly larger in STZ-ICR than LPS-ICR. It is well-
established that severe periodontitis causes bacteremia
and microorganisms of the oral cavity enter the systemic
circulation, and that large amounts of LPS produced in
Fig. 6 Quantitative analysis of the immunostaining of renal physiologically active molecules, leukocyte adhesion molecules, and leukocytes.
Immunostained areas were measured in microscopic images by ImageJ. Relative expression area was expressed by arbitrary unit: Positive area of
ICR (no treatment), STZ-ICR (STZ) and LPS-STZ / the area of LPS-ICR (LPS). The VCAM-1, E-selectin, Mac-1, podoplanin, FGF-23, and ACE2 positive
area were significantly larger in LPS-STZ (*) than in ICR, LPS or STZ. The Mac-1 and podoplanin positive area were significantly larger in STZ (**)
than in ICR, or LPS. *,**Significantly different by one-way ANOVA
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P. gingivalis act as a risk factor in cardiovascular disor-
ders [53–55]. It has been thought that AGE induces
TLR expression in several somatic cells and that AGE is
recognized by TLR as well as AGE receptor [6–8]. We
recently reported that the glomerular endothelium of
diabetic mice expresses TLR2 and TLR4, and that the
TLR2/4-ligand P. gingivalis LPS causes glomerulosclero-
sis in diabetic mice with the accumulation of type 1 col-
lagen and inflammatory cytokines in glomeruli [27–29].
Considering the present study, it was thought that Pg-
LPS induced diabetic renal inflammation such as glo-
merulosclerosis and tubulitis with infiltration of Mac-1/
podoplanin positive macrophages via glomerular overex-
pression of VCAM-1 and E-selectin, resulting in accu-
mulation of both ACE2 and FGF23 which were
unmetabolized with the inflammation-induced kidney
damage under the diabetic condition (Fig. 7). As neph-
ritis progresses, physiologically active substances and en-
zymes accumulate without being metabolized due to
renal dysfunction. The compensatory productions to
recover from dysfunction accelerate the accumulation in
the kidneys and elevates the blood levels at terminal
stages, and hyperphosphatemia simultaneously occurs
because phosphorus cannot be excreted due to damage
of renal tubules. Periodontal disease may contribute to
the progression of stage in diabetic patients.
Conclusion
It may be postulated that periodontitis provokes chronic
renal inflammation by the renal overexpression of
leukocyte adhesion molecules in diabetes patients with
the renal accumulation of physiologically active
substances.
Supplementary Information
The online version contains supplementary material available at https://doi.
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Additional file 1 Supplementary 1. Immunostaining of VCAM-1, E-
selectin and Mac-1 in ICR. Hematoxylin-Eosin staining (HE) (left column);
Fig. 7 Prediction of complex etiology of P. gingivalis LPS-induced diabetic nephropathy. Severe periodontitis causes bacteremia and
microorganisms of the oral cavity enter kidneys through the systemic circulation. AGE induces renal TLR expression, recognized by TLR2/4, and
promotes the expression of cytokines and leukocyte adhesion molecule VCAM-1, and E-selectin. Inflammatory infiltration of Mac-1/podoplanin
positive macrophages causes with overexpression of leukocyte adhesion molecules in P. gingivalis LPS-accumulated renal glomeruli, and
simultaneously ACE2 overexpression and bone-derived FGF23 accumulation promote tubulitis and diabetic nephropathy with hypertensive
renal diseases
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immunostaining (center column) for VCAM-1 (top row), E-selectin (middle
row), and Mac-1 (red, bottom row); and merged immunostaining (right
column) for VCAM-1/E-selectin/Mac-1 with podoplanin (green) and DAPI
staining of nuclei (blue). The glomerular epithelial cells were immuno-
stained by anti-podoplanin to be able to discriminate glomeruli (arrows).
Reaction products were not identified for anti-VCAM-1 and anti-E-selectin;
rarely identified for anti-Mac-1 (arrowheads). Bars: 100 μm.
Additional file 2 Supplementary 2. Immunostaining of FGF23 and
ACE2 in ICR. Hematoxylin-Eosin staining (HE) (left column); immunostain-
ing (center column) for FGF23 (top row) and ACE2 (bottom row); and
merged immunostaining (right column) for FGF23/ACE2 with podoplanin
(green) and DAPI staining of nuclei (blue). The glomerular epithelial cells
were immunostained by anti-podoplanin to be able to discriminate
glomeruli (arrows). Reaction products were not identified for anti-FGF23;
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